Enhanced Models for Cancer Survivorship

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Kansas Medical Center

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new methods to help rural doctors provide better care for cancer survivors. It focuses on using technology and education to improve how doctors track patient health and identify areas needing attention. Cancer survivors of breast, prostate, lung, or colorectal cancer living in rural areas may find this trial suitable. The trial involves three approaches: team-based care, virtual assistants, and enhanced usual care. These aim to ensure survivors receive the right support and follow-up care after cancer treatment. As an unphased trial, it offers a unique opportunity to contribute to innovative solutions that could enhance healthcare for rural cancer survivors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these implementation strategies are safe for improving cancer survivorship care?

Research has shown that both the KanSurvive telementoring and education program and practice facilitation for quality improvement have been well-received in previous studies. The KanSurvive program offers remote guidance and education to healthcare providers, aiding them in better caring for cancer survivors. As this program does not involve direct medical treatment for patients, there are no known safety concerns for participants.

Similarly, practice facilitation assists healthcare teams in enhancing their services, particularly in rural areas. This method aims to improve the quality of care for cancer survivors by helping clinics identify and address gaps in care. Since it focuses on improving processes rather than directly treating patients, it is considered safe with no reported negative effects.

Both strategies emphasize education and process improvement, which are non-invasive and pose no direct risk to those considering joining a trial.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to enhance care for cancer survivors, particularly in rural areas. Unlike traditional face-to-face follow-ups, the KanSurvive telementoring and education approach leverages technology to provide ongoing support and education to healthcare providers remotely. This could bridge significant gaps in care by keeping providers up-to-date on best practices without needing them to leave their communities. Additionally, the trial's focus on practice facilitation aims to improve the quality of care through team-based approaches and virtual scribe medical assistants. These methods could streamline clinical documentation and identify care opportunities more efficiently, ultimately leading to better outcomes for cancer survivors.

What evidence suggests that this trial's treatments could be effective for cancer survivorship care?

Research has shown that the KanSurvive telementoring and education program can enhance the quality of care for cancer survivors. In this trial, participants may join the "Virtual Scribe Medical Assistant" arm, which uses KanSurvive 2.0 Project ECHO education to aid in clinical documentation and identify care gaps. Alternatively, participants might join the "Team Based Care" arm, where rural primary care practice teams concentrate on quality improvement through practice facilitation. Both methods aim to equip healthcare providers with the knowledge and tools necessary to offer improved care to cancer survivors. This can result in more personalized and effective treatment plans, particularly in resource-limited areas. Overall, these approaches strive to ensure that cancer survivors receive the comprehensive care needed after treatment.16789

Who Is on the Research Team?

AK

Allen K Greiner, MD, MPH

Principal Investigator

University of Kansas Medical Center

Are You a Good Fit for This Trial?

This trial is for rural primary care practices in Kansas with multiple providers, at least one medical assistant, and a scribe or willingness to hire one. It focuses on breast, prostate, lung, or colorectal cancer survivors expected to live at least 24 more months.

Inclusion Criteria

My primary care practice has at least one medical assistant.
4. PCPs must have an employed medical scribe or be willing to consider employing a medical scribe using study compensation and practice revenue
1. Rural primary care practice (PCP) located within rural urban continuum codes (RUCC) 4-9 in Kansas
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Formative evaluations assess current systems of care and practice-level barriers and facilitators for the delivery of EBP cancer survivorship care

Baseline

Intervention

Three-arm cluster-randomized intervention to provide education, tele-mentoring, and assess the effectiveness of virtual scribes, team-based approach, or usual care

24 months
Regular visits as per intervention arm

Follow-up

Participants are monitored for sustainability of intervention activities and adherence to cancer survivorship guidelines

12 and 24 months post-implementation

What Are the Treatments Tested in This Trial?

Interventions

  • KanSurvive telementoring and education
  • Practice facilitation for quality improvement

Trial Overview

The study tests ways to improve survivorship care for rural cancer survivors by providing telementoring and education for providers, practice support for quality improvement, a survivorship care manual, virtual scribe services, and an obesity management toolkit.

How Is the Trial Designed?

3

Treatment groups

Active Control

Placebo Group

Group I: Team Based CareActive Control3 Interventions
Group II: Virtual Scribe Medical AssistantActive Control4 Interventions
Group III: Enhanced Usual CarePlacebo Group3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials
527
Recruited
181,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Citations

KanSurvive 2.0

The primary outcome is practice level completion and documentation of cancer survivorship care as measured using a previously developed composite scoring system ...

KANSURVIVE: Testing a telementoring model for ...

KanSurvive, a single arm feasibility trial, evaluated the effectiveness of the KanSurvive ECHO intervention combined with practice facilitation (PF)

ELEMENTS OF A RESEARCH PROTOCOL

Evaluate the effectiveness of KanSurvive-ECHO for enhancing evidence-based survivorship care for rural breast, colorectal, lung, and prostate cancer survivors.

KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship ...

The primary outcome is provider adherence to EBP cancer survivorship guidelines as measured using a previously developed composite scoring system that compares ...

Testing a telementoring model for improving cancer ...

Standardized survivorship metrics can facilitate quality assessment as part of an ECHO-based cancer survivorship program and PCPs in this study caring for ...

KanSurvive 2.0 Helps Cancer Survivors Stay Healthy in ...

This NCI-funded initiative will test new ways to help rural doctors provide high-quality, long-term care for cancer survivors.

Testing Enhanced Models of Cancer Survivorship Care for ...

Telementoring, education, and case-based learning covering evidence-based practice guidelines for breast, colorectal, lung, and prostate cancer survivorship.

Enhanced Models for Cancer Survivorship

This N/A medical study run by University of Kansas Medical Center needs participants to evaluate whether KanSurvive telementoring and education and Practice ...

Testing a Model for Improving Cancer Survivorship Care in ...

The KanSurvive project includes Project ECHO telementoring and education with practice facilitation to improve the delivery of cancer ...